The Trustees of the University of Pennsylvania;Inovio Pharmaceuticals, Inc.
发明人:
Weiner, David,Lang, Krystle,Yan, Jian,Draghia-Akli, Ruxandra,Khan, Amir
申请号：
AU2017272205
公开号：
AU2017272205A1
申请日:
2017.12.06
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2017272205A120180104.pdf#####ABSTRACT Improved anti-HCV immunogens and nucleic acid molecules that encode them are disclosed. Immunogens disclosed include those having consensus HCV genotype 1 a, including for example, NS4B, NS5A and NS5B. Pharmaceutical composition, 5 recombinant vaccines comprising and live attenuated vaccines are disclosed as well methods of inducing an immune response in an individual against HCV are disclosed.
